TR201714882A2 - Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari - Google Patents

Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari Download PDF

Info

Publication number
TR201714882A2
TR201714882A2 TR2017/14882A TR201714882A TR201714882A2 TR 201714882 A2 TR201714882 A2 TR 201714882A2 TR 2017/14882 A TR2017/14882 A TR 2017/14882A TR 201714882 A TR201714882 A TR 201714882A TR 201714882 A2 TR201714882 A2 TR 201714882A2
Authority
TR
Turkey
Prior art keywords
luliconazole
pharmaceutical compositions
topical pharmaceutical
pharmaceutically acceptable
polymorphs
Prior art date
Application number
TR2017/14882A
Other languages
English (en)
Inventor
Ulusoy Bozyel Müge
Zengi̇ner Si̇bel
Türkyilmaz Ali̇
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/14882A priority Critical patent/TR201714882A2/tr
Priority to PCT/TR2018/050542 priority patent/WO2019070221A1/en
Publication of TR201714882A2 publication Critical patent/TR201714882A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, lulikonazol veya lulikonazolün farmasötik olarak kabul edilebilir tuzlarını, polimorflarını, stereoizomerlerini, solvatlarını, hidratlarını veya esterlerini ve en az bir farmasötik olarak kabul edilebilir eksipiyan içeren topikal farmasötik kompozisyonlarla ilgilidir.
TR2017/14882A 2017-10-03 2017-10-03 Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari TR201714882A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2017/14882A TR201714882A2 (tr) 2017-10-03 2017-10-03 Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari
PCT/TR2018/050542 WO2019070221A1 (en) 2017-10-03 2018-10-02 TOPICAL PHARMACEUTICAL COMPOSITIONS OF LULICONAZOLE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/14882A TR201714882A2 (tr) 2017-10-03 2017-10-03 Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari

Publications (1)

Publication Number Publication Date
TR201714882A2 true TR201714882A2 (tr) 2019-04-22

Family

ID=65276258

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/14882A TR201714882A2 (tr) 2017-10-03 2017-10-03 Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari

Country Status (2)

Country Link
TR (1) TR201714882A2 (tr)
WO (1) WO2019070221A1 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114259462A (zh) * 2021-12-13 2022-04-01 海南海灵化学制药有限公司 一种含有卢立康唑的外用乳膏组合物
JP2025066191A (ja) * 2022-01-19 2025-04-23 日本農薬株式会社 抗真菌薬点眼剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1091596C (zh) 1995-07-08 2002-10-02 日本农药株式会社 抗真菌剂及其化合物和它们的制备方法
JP5184342B2 (ja) 2006-03-08 2013-04-17 日本農薬株式会社 外用の医薬組成物
JP5184341B2 (ja) 2006-03-08 2013-04-17 日本農薬株式会社 外用の医薬組成物
PL2005958T3 (pl) 2006-03-08 2013-11-29 Nihon Nohyaku Co Ltd Kompozycja farmaceutyczna do stosowania zewnętrznego
US8492421B2 (en) * 2007-08-27 2013-07-23 Nihon Nohyaku Co., Ltd. Agent for fungal dermatitis
JP5941909B2 (ja) * 2011-04-27 2016-06-29 マルホ株式会社 イミダゾール系抗真菌薬を含有する懸濁性ローション剤
JP5589130B1 (ja) 2012-09-14 2014-09-10 株式会社ポーラファルマ 結晶及び該結晶を含有してなる医薬製剤
JP5589110B1 (ja) * 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
CN105263525A (zh) * 2013-04-12 2016-01-20 维奥姆生物科学有限公司 抗微生物剂的组合物和制剂、它们的方法以及用于治疗微生物感染的方法

Also Published As

Publication number Publication date
WO2019070221A1 (en) 2019-04-11

Similar Documents

Publication Publication Date Title
MY210123A (en) Tlr7/8 antagonists and uses thereof
MY190835A (en) Bicyclic heterrocyclic derivatives as bromodomain inhibitors
ZA201606320B (en) Human plasma kallikrein inhibitors
SG10201811384TA (en) Mnk inhibitors and methods related thereto
MX2020010690A (es) Oxiesteroles y metodos de uso de los mismos.
MA39956A (fr) Analogues du benzomorphane et leur utilisation
MX2016013431A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
TN2016000489A1 (en) Carboxamide derivatives.
TR201721505A2 (tr) Li̇nagli̇pti̇n ve metformi̇n i̇çeren kombi̇nasyon
TR201714882A2 (tr) Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari
PH12016502480A1 (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
IN2014MU00859A (tr)
PH12017501736A1 (en) Indole derivatives
MX2017002544A (es) Derivados de isoquinolinona utiles en el tratamiento contra el cancer.
IN2013MU03308A (tr)
WO2019004980A3 (en) SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF DABIGATRAN DEXILATE
MX2016013428A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
IN2013MU03309A (tr)
PH12020500385A1 (en) A process for preparation of triaminopyrimidine compound and intermediates thereof
IN2013MU03421A (tr)
MX2016005539A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
MX2018010652A (es) Composiciones farmaceuticas.
MX2017010992A (es) Composiciones farmaceuticas estables que comprenden agente antibacteriano.
IN2014MU01194A (tr)
NZ759901A (en) Solid oral pharmaceutical compositions of dabigatran etexilate